7.445
Precedente Chiudi:
$7.59
Aprire:
$7.35
Volume 24 ore:
3.40M
Relative Volume:
0.46
Capitalizzazione di mercato:
$1.32B
Reddito:
$2.54B
Utile/perdita netta:
$-207.36M
Rapporto P/E:
-6.2563
EPS:
-1.19
Flusso di cassa netto:
$151.25M
1 W Prestazione:
+2.75%
1M Prestazione:
-13.68%
6M Prestazione:
+7.65%
1 anno Prestazione:
-37.82%
Teladoc Health Inc Stock (TDOC) Company Profile
Nome
Teladoc Health Inc
Settore
Industria
Telefono
(203) 635-2002
Indirizzo
155 E 44TH STREET, NEW YORK, NY
Confronta TDOC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
TDOC
Teladoc Health Inc
|
7.445 | 1.35B | 2.54B | -207.36M | 151.25M | -1.19 |
|
VEEV
Veeva Systems Inc
|
240.93 | 39.50B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
74.56 | 13.86B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
102.12 | 9.06B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
50.96 | 9.68B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
36.30 | 7.06B | 906.14M | -52.62M | 89.62M | -0.3621 |
Teladoc Health Inc Stock (TDOC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-13 | Iniziato | BMO Capital Markets | Market Perform |
| 2025-07-25 | Iniziato | Mizuho | Neutral |
| 2024-11-15 | Iniziato | Goldman | Buy |
| 2024-09-17 | Reiterato | Jefferies | Hold |
| 2024-02-29 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-02-26 | Iniziato | Leerink Partners | Market Perform |
| 2024-01-17 | Downgrade | DA Davidson | Buy → Neutral |
| 2024-01-03 | Iniziato | Barclays | Overweight |
| 2023-04-12 | Iniziato | Stephens | Equal-Weight |
| 2023-02-23 | Aggiornamento | SVB Securities | Market Perform → Outperform |
| 2022-10-24 | Aggiornamento | Guggenheim | Sell → Neutral |
| 2022-09-16 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Iniziato | Truist | Hold |
| 2022-08-17 | Downgrade | Guggenheim | Neutral → Sell |
| 2022-08-12 | Iniziato | DA Davidson | Buy |
| 2022-08-02 | Downgrade | Berenberg | Buy → Hold |
| 2022-08-02 | Downgrade | Cowen | Outperform → Market Perform |
| 2022-07-28 | Downgrade | Goldman | Buy → Neutral |
| 2022-07-28 | Downgrade | Needham | Buy → Hold |
| 2022-07-06 | Reiterato | BofA Securities | Neutral |
| 2022-05-05 | Downgrade | Argus | Buy → Hold |
| 2022-04-28 | Downgrade | Citigroup | Buy → Neutral |
| 2022-04-28 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2022-04-28 | Downgrade | Guggenheim | Buy → Neutral |
| 2022-04-28 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-04-28 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-28 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-04-28 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2022-04-07 | Iniziato | Guggenheim | Buy |
| 2022-04-01 | Ripresa | Credit Suisse | Outperform |
| 2022-03-03 | Aggiornamento | Argus | Hold → Buy |
| 2022-02-23 | Reiterato | BofA Securities | Neutral |
| 2022-02-23 | Reiterato | Craig Hallum | Hold |
| 2022-02-23 | Reiterato | Evercore ISI | In-line |
| 2022-02-23 | Reiterato | Goldman | Buy |
| 2022-02-23 | Reiterato | JP Morgan | Overweight |
| 2022-02-23 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2022-02-23 | Reiterato | Needham | Buy |
| 2022-02-23 | Reiterato | Oppenheimer | Outperform |
| 2022-02-23 | Reiterato | Stifel | Hold |
| 2022-02-11 | Iniziato | Goldman | Buy |
| 2022-02-08 | Reiterato | Piper Sandler | Overweight |
| 2021-12-02 | Ripresa | Jefferies | Hold |
| 2021-11-22 | Downgrade | BTIG Research | Buy → Neutral |
| 2021-10-28 | Reiterato | Barclays | Equal Weight |
| 2021-10-28 | Reiterato | BofA Securities | Neutral |
| 2021-10-28 | Reiterato | Canaccord Genuity | Buy |
| 2021-10-28 | Reiterato | Citigroup | Buy |
| 2021-10-28 | Reiterato | Craig Hallum | Hold |
| 2021-10-28 | Reiterato | Needham | Buy |
| 2021-10-28 | Reiterato | Oppenheimer | Outperform |
| 2021-10-28 | Reiterato | Piper Sandler | Overweight |
| 2021-10-28 | Reiterato | UBS | Neutral |
| 2021-10-19 | Iniziato | Wells Fargo | Overweight |
| 2021-08-02 | Downgrade | Argus | Buy → Hold |
| 2021-07-28 | Downgrade | Deutsche Bank | Buy → Hold |
| 2021-05-28 | Iniziato | Robert W. Baird | Neutral |
| 2021-04-15 | Iniziato | Needham | Buy |
| 2021-01-07 | Iniziato | BTIG Research | Buy |
| 2020-12-22 | Iniziato | Evercore ISI | In-line |
| 2020-12-07 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2020-12-04 | Iniziato | Goldman | Neutral |
| 2020-11-13 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2020-09-22 | Iniziato | DA Davidson | Buy |
| 2020-09-02 | Aggiornamento | Berenberg | Hold → Buy |
| 2020-08-17 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-07-14 | Iniziato | Citigroup | Buy |
| 2020-07-13 | Iniziato | Argus | Buy |
| 2020-07-07 | Iniziato | Stephens | Overweight |
| 2020-04-30 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2020-04-13 | Iniziato | SVB Leerink | Outperform |
| 2020-03-31 | Downgrade | Berenberg | Buy → Hold |
| 2020-03-25 | Downgrade | Craig Hallum | Buy → Hold |
| 2020-03-16 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-12 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-02-28 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-12 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2020-01-10 | Iniziato | UBS | Neutral |
| 2020-01-09 | Downgrade | BofA/Merrill | Buy → Neutral |
Mostra tutto
Teladoc Health Inc Borsa (TDOC) Ultime notizie
Why Is Teladoc (TDOC) Down 14.8% Since Last Earnings Report? - sharewise.com
Teladoc Health to Participate in Upcoming Investor Conference - Enidnews.com
Teladoc Health's Q3 Loss Widens Y/Y on Weak BetterHelp Unit - MSN
Is Teladoc Stock a Buy After Oracle Investment Management Upped Its Stake? - AOL.com
The Technical Signals Behind (TDOC) That Institutions Follow - news.stocktradersdaily.com
B of A Securities Maintains Teladoc Health (TDOC) Neutral Recommendation - Nasdaq
Teladoc Health (TDOC): Assessing Valuation After Recent Short-Term Share Price Rebound - Yahoo Finance
Teladoc Health (TDOC): B of A Securities Lowers Price Target | T - GuruFocus
Teladoc Health (TDOC): Evaluating Valuation After TytoCare Partnership and New AI Diagnostic Integration - Sahm
Teladoc, Angi, Upwork, and ACV Auctions Shares Are Soaring, What You Need To Know - Finviz
Teladoc Health, Inc. (NYSE:TDOC) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough - simplywall.st
Teladoc Health Inc Stock Analysis and ForecastMarket Rumors and News & Get Free Expert Trading Recommendations - earlytimes.in
Does Teladoc's Acquisition Strategy Boost Growth and Global Footprint? - Nasdaq
Why Teladoc Health Inc. (4LL) stock could rally stronglyMarket Sentiment Review & Risk Adjusted Buy/Sell Alerts - newser.com
Teladoc Boosts Weight Care Access With LillyDirect, Aids Growth - MSN
Is Teladoc Health Inc. stock attractive post correctionAnalyst Downgrade & Risk Controlled Daily Plans - newser.com
Why Teladoc Health Inc. stock could outperform next yearEarnings Overview Summary & Consistent Return Strategy Ideas - newser.com
Teladoc and Netflix Shares Are Falling, What You Need To Know - Finviz
TDOC vs. LFMD: Which Telehealth Stock Is Better for Your Portfolio? - sharewise.com
Could TytoCare Collaboration Reveal Shifts in Teladoc Health's (TDOC) Virtual Care Strategy? - Yahoo Finance
Why pension funds invest in Teladoc Health Inc. (4LL) stock2025 Performance Recap & Step-by-Step Swing Trade Plans - newser.com
Why Teladoc Health Inc. stock trades below fair valueJuly 2025 Weekly Recap & High Conviction Buy Zone Alerts - newser.com
Will Teladoc Health Inc. stock benefit from upcoming earnings reportsWeekly Market Report & Growth Focused Stock Reports - newser.com
Online Marketplace Stocks Q3 Highlights: Teladoc (NYSE:TDOC) - Finviz
Will Teladoc Health Inc. stock sustain uptrend momentumMarket Sentiment Report & Technical Pattern Alert System - newser.com
How Teladoc Health Inc. (4LL) stock compares with top peers2025 Price Momentum & Low Drawdown Investment Ideas - newser.com
Is Teladoc Health Inc. stock attractive for growth fundsRate Hike & Low Risk Investment Opportunities - newser.com
How to integrate Teladoc Health Inc. into portfolio analysis tools2025 Major Catalysts & High Yield Equity Trading Tips - newser.com
Can Teladoc Health Inc. stock stage a strong rebound this quarterJuly 2025 Opening Moves & Expert Curated Trade Setups - newser.com
Is Teladoc Health Inc. stock cheap at current valuationInsider Selling & Real-Time Stock Movement Alerts - newser.com
How Teladoc Health Inc. (4LL) stock behaves under inflation pressureMarket Risk Analysis & Weekly Watchlist of Top Performers - newser.com
Can Teladoc Health Inc. (4LL) stock reach $200 price targetJuly 2025 Closing Moves & Weekly Top Gainers Alerts - newser.com
Is Teladoc Health Inc. (4LL) stock nearing a technical breakoutJuly 2025 Sector Moves & Fast Entry and Exit Trade Plans - newser.com
Teladoc Health Inc Azioni (TDOC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):